The Stem Cell Platform (SCP) at the University of Lübeck provides investigators with cutting-edge stem cell technologies by using human induced pluripotent stem cells (iPSCs).
The SCP Lübeck has been launched in 2021 and is located at the Institute of Neurogenetics.
SCP researchers have long-standing expertise in iPSC technology and specialized in using human iPSCs to model diseases. Apart from the generation of iPSCs, differentiation protocols into various neuronal subtypes, microglia, cardiomyocytes as well as brain organoids are established at the platform laboratory.
The SCP is an integral part of several local and international research projects, including the Research Unit ProtectMove and the Cluster of Excellence Precision Medicine in Chronic inflammation and projects supported by the Michael J. Fox Foundation and the Collaborative Center for XDP.